HRMY
NASDAQ · Pharmaceuticals
Harmony Biosciences Holdings
$38.41
-0.34 (-0.88%)
Analyst Consensus
Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
+143.5% upside
Low Target
$67.60
Average Target
$93.52
High Target
$113.52
Current Price
$38.41
Current
$38.41
$38.41
Target
$93.52
$93.52
$67.60
$93.52 avg
$113.52
Scenario Analysis
Bear Case
$67.60
76.0%
Low target
Base Case
$93.52
+143.5%
Avg target
Bull Case
$113.52
+195.5%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$40.87
-6.0% from high
52-Week Low
$25.52
+50.5% from low
50-Day SMA
$37.42
+2.6% vs SMA
200-Day SMA
$34.21
+12.3% vs SMA
RSI (14)
38.4
Neutral
Target vs 52W High
$93.52
+128.8% vs high
Next Earnings Report
Aug 11, 2026
1d
tomorrow
EPS Est: $0.95
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals